Literature DB >> 10751093

Characterization of four arylsulfatase A missense mutations G86D, Y201C, D255H, and E312D causing metachromatic leukodystrophy.

S Hermann1, F Schestag, A Polten, S Kafert, J Penzien, J Zlotogora, N Baumann, V Gieselmann.   

Abstract

Metachromatic leukodystrophy is a lysosomal storage disease caused by the deficiency of arylsulfatase A. Here we describe a hitherto unknown arylsulfatase A allele carrying a E312D missense mutation and characterize the effects of this and three previously described missense mutations, G86D, Y201C, and D255H, on arylsulfatase A. In transfection experiments no enzyme activity can be expressed from arylsulfatase A cDNAs coding for the D255H substituted enzyme, whereas Y201C and E312D mutations were associated with low amounts of residual enzyme activity. All amino acid substitutions lead to a decreased stability of the mutant enzyme, and metabolic labeling experiments indicated that except for the E312D substitution the mutations cause arrest of the mutant arylsulfatase A polypeptides in a prelysosomal compartment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751093     DOI: 10.1002/(sici)1096-8628(20000306)91:1<68::aid-ajmg13>3.0.co;2-g

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

Review 1.  Allelic variation and environmental lead exposure in urban children.

Authors:  Jacquelyn Long; Chandice Covington; Virginia Delaney-Black; Beth Nordstrom
Journal:  AACN Clin Issues       Date:  2002-11

2.  Cerebral gray and white matter changes and clinical course in metachromatic leukodystrophy.

Authors:  Samuel Groeschel; Christine í Dali; Philipp Clas; Judith Böhringer; Morten Duno; Christian Krarup; Christiane Kehrer; Marko Wilke; Ingeborg Krägeloh-Mann
Journal:  Neurology       Date:  2012-09-19       Impact factor: 9.910

3.  An Italian cohort study identifies four new pathologic mutations in the ARSA gene.

Authors:  Daniela Galla; Paola de Gemmis; Laura Anesi; Silvia Berto; Diego Dolcetta; Uroš Hladnik
Journal:  J Mol Neurosci       Date:  2013-04-05       Impact factor: 3.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.